TXMD icon

TherapeuticsMD
TXMD

Overview Fund Trends Analyst Outlook Journalist POV

38 hedge funds and large institutions have $5.49M invested in TherapeuticsMD in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$31K
Puts
$7K
Net Calls
Net Calls Change

Top Buyers

1
+$163K
2
+$23.1K
3
+$17.2K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.05K
5
UBS Group
UBS Group
Switzerland
+$2.1K

Top Sellers

1
-$59.1K
2
-$56.1K
3
-$31K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$23.3K
5
BlackRock
BlackRock
New York
-$17.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$196
27
$193
28
$129
29
$90
30
$64
31
$32
32
$13
33
$4
34
$3
35
$2
36
$2
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2